KEGG DRUG

Search results

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	指定難病告示番号
1	ABP 959 - biosimilar to eculizumab (Soliris (TN))	1件: Eculizumab (Soliris)	1件: Eculizumab (Soliris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 62 💬
2	ABP 959 - proposed biosimilar to eculizumab (Soliris (TN))	1件: Eculizumab (Soliris)	1件: Eculizumab (Soliris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 62 💬
3	ECULIZUMAB (Soliris (TN))	1件: Eculizumab (Soliris)	1件: Eculizumab (Soliris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	7件: 11, 13, 14, 61, 62, 109, 222 💬
4	SB12 (proposed eculizumab biosimilar) (Soliris (TN))	1件: Eculizumab (Soliris)	1件: Eculizumab (Soliris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 62 💬
5	SOLIRIS	1件: Eculizumab (Soliris)	1件: Eculizumab (Soliris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	7件: 11, 13, 14, 61, 62, 109, 222 💬
6	Soliris (eculizumab)	1件: Eculizumab (Soliris)	1件: Eculizumab (Soliris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 62 💬
7	Soliris (R)	1件: Eculizumab (Soliris)	1件: Eculizumab (Soliris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 61 💬
8	SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML)	1件: Eculizumab (Soliris)	1件: Eculizumab (Soliris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	3件: 13, 62, 109 💬
9	Soliris 300	1件: Eculizumab (Soliris)	1件: Eculizumab (Soliris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 62 💬
10	SOLIRIS 300 mg concentrado para solución para perfusión	1件: Eculizumab (Soliris)	1件: Eculizumab (Soliris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 109 💬
11	Soliris 300 mg concentrate for solution for infusion	1件: Eculizumab (Soliris)	1件: Eculizumab (Soliris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 62 💬
12	Soliris 300mg/30ml	1件: Eculizumab (Soliris)	1件: Eculizumab (Soliris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 62 💬
13	Soliris ™ (eculizumab)	1件: Eculizumab (Soliris)	1件: Eculizumab (Soliris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 62 💬
14	Soliris®	1件: Eculizumab (Soliris)	1件: Eculizumab (Soliris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 62 💬
15	SOLIRIS® (eculizumab) injection, for intravenous use	1件: Eculizumab (Soliris)	1件: Eculizumab (Soliris (TN)) 💬	1件: C5 💬	11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬	1件: 62 💬